'Digital Pill' Tells Doctor When Patient Takes It

Ebony Scott
November 15, 2017

"The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers", Dr. Mitchell Mathis, director of the division of Psychiatry Products in the FDA's Center for Drug Evaluation and Research, said in a statement.

Abilify MyCite (aripiprazole with sensor) has an embedded sensor that sends a message to a wearable patch that the medication's been taken. And the drug shouldn't be used in an attempt to track "real-time" ingestion, since detection could be delayed, the agency added.

This patch then transmits the information to a mobile app, so that a doctor and up to four caregivers, friends or family members can see the information through a web-based portal.

Bipolar disorder, also known as manic-depressive illness, is another brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. The FDA does warn that the digital sensor may not always register a dose, though, and for that reason it shouldn't be used in emergency situations.

According to the news release, the FDA granted the approval of Abilify MyCite to Otsuka Pharmaceutical Co., Ltd.

California launch of new USA weather satellite postponed
Crews have postponed this morning's expected launch of a rocket that would have carried Idaho's first satellite into space. The CubeSat is the first of four planned as part of the JPSS series.

Senate poised to act on same-sex marriage
Senator Paterson believes state and federal anti-discrimination laws aren't strong enough. No notice has yet been given for the Paterson bill.

GameStop Temporarily Suspends Unlimited Used Games Power Pass Program
If you were looking forward to becoming one of GameStop's PowerPass subscribers later this month, we have some bad news for you. At the end of the six months, customers would be allowed to keep one of the games they had rented during that timespan.

Abilify MyCite is not approved to treat patients with dementia-related psychosis and contains a boxed warning alerting health care professionals that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.

What are some potentially unsafe risks of Abilify MyCite? The safety and effectiveness of Abilify MyCite have not been established in pediatric patients. It's also been pointed out that as schizophrenia symptoms often include paranoia, it's unlikely that every patient will be willing to take a meditation that monitors behavior in such a way. Abilify MyCite must be dispensed with a patient medication guide that describes important information about the drug's uses and risks.

Ablify MyCite is a version of aripiprazole tablets that have a sensor inside. A report from the IMS Institute for Healthcare Informatics estimates that the cost of patients not taking their medication correctly is about $100 billion each year.

The technology is the product of research between Japanese pharmaceutical company Otsuka and Proteus Digital Health, and is created to solve the problem of people missing medicine doses, which costs the US healthcare system an estimated $200 billion per year.

Other reports by GizPress

Discuss This Article

FOLLOW OUR NEWSPAPER